Moe Alsumidaie

Articles

New Compliance Issues Emerge Amidst COVID Clinical Operations

October 20, 2020

A discussion of the forces currently impacting global operations, FDA foresight on operating clinical studies during COVID, and the subsequent compliance issues manifesting from poorly executed decentralized clinical trial operations.

COVID Shifts Clinical Innovation in Big Pharma

October 16, 2020

Hassan Kadhim, Director, Global Head of Clinical Trial Business Capabilities, Clinical Innovation & Industry Collaborations at Bristol Myers Squibb, discusses his perspectives on how the pandemic has shifted clinical innovation.

Genetic-Based Testing Enters Clinical Trials

January 30, 2020

With the biopharma industry making strides in gene therapies by focusing on patients with specific genetic traits, Karmen Trzupek, Director of Clinical Trial Services at InformedDNA, discusses how to address the presented challenges of this approach.

What Will Happen When We Automate Clinical Trials?

January 21, 2020

While the clinical trials industry has always been a slacker in innovation, we'll soon start seeing automation and artificial intelligence significantly impacting the way biopharmaceutical enterprises run clinical trials, says Moe Alsumidaie.

R&D in Hard-to-Treat Fungal Infections Advances

November 26, 2019

Patrick Jordan, Chief Executive Officer of Mycovia, discusses the company's strategies on tackling Recurrent Vulvovaginal Candidiasis.